Björn Ekström has become CEO of Olink Bioscience, a Swedish startup focusing on protein analysis technology. Previously, Ekström was head of R&D at Pyrosequencing. He also held several positions within R&D at Amersham Biosciences and Pharmacia Biotech.
Midwest BioResearch, which provides outsourced drug disposition and toxicology services, has appointed Charles Jeuell as its vice president of analytical operations and Anna Koostra as a senior-level research scientist in the company’s protein bioanalysis group, the company said last week.
Thomas Heydler has been appointed the new CEO of Definiens, a Munich, Germany-based company that specializes in providing high-content image analysis software.
Prior to joining Definiens, Heydler was president and CEO at InterPro Business Solutions and Barcelona Design. Before that, he was vice president and executive officer at Documentum, a pharmaceutical and life sciences software company.